02393.HK
Yestar Healthcare Holdings Company Limited
HKSE · Healthcare · Medical - Devices · CN
HKD 0.05
−6.90%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 3.3B | 1.5B | 2.4B | 2.9B | 2.8B |
| Cost of Revenue | 2.7B | 1.2B | 2.0B | 2.4B | 3.6B |
| Gross Profit | 593.4M | 266.9M | 399.2M | 512.8M | 397.6M |
| Operating Expenses | |||||
| R&D Expense | 45.2M | 11.4M | 33.8M | — | 21.2M |
| SG&A Expense | 502.6M | 238.3M | 362.4M | 380.6M | 364.9M |
| General & Admin Expense | 257.5M | 149.4M | 210.0M | 264.2M | 193.7M |
| Selling & Marketing Expense | 164.9M | 88.9M | 152.4M | 116.4M | 171.2M |
| Other Expenses | 210.3M | 16.4M | (23.8M) | (11.4M) | 139.5M |
| Total Operating Expenses | 758.1M | 266.1M | 372.4M | 369.2M | 525.5M |
| Cost and Expenses | 3.5B | 1.5B | 2.6B | 2.8B | 2.9B |
| Operating Income (EBIT) | (164.8M) | 771.0K | (153.7M) | 143.6M | (128.0M) |
| Non-Operating | |||||
| Interest Income | — | 1.1M | 1.5M | 2.4M | 5.0M |
| Interest Expense | 22.6M | 10.9M | 30.2M | 164.7M | 273.1M |
| Net Interest Income | (22.6M) | (9.8M) | (28.7M) | (162.3M) | (268.2M) |
| Other Non-Op Income/Expense | (53.4M) | (52.6M) | 1.1B | (102.5M) | (356.8M) |
| Non-Operating Income (excl Interest) | (45.2M) | (11.4M) | (33.8M) | (62.2M) | 254.4M |
| EBT (Pre-Tax Income) | (218.1M) | (51.8M) | 929.6M | 41.0M | (484.8M) |
| Income Tax Expense | 41.1M | 17.4M | 26.7M | 39.6M | (10.8M) |
| Bottom Line | |||||
| Net Income | (245.8M) | (75.0M) | 921.6M | (13.9M) | (992.2M) |
| Earnings from Cont. Ops | (259.2M) | (69.2M) | 903.0M | 1.5M | (473.9M) |
| Earnings from Discont. Ops | — | — | 536.0K | (2.7M) | (531.9M) |
| Bottom Line Net Income | (245.8M) | (75.0M) | 921.1M | (13.9M) | (460.3M) |
| Per Share | |||||
| Basic EPS | (HK$0.11) | (HK$0.03) | HK$0.40 | (HK$0.01) | (HK$0.20) |
| Diluted EPS | (HK$0.11) | (HK$0.03) | HK$0.40 | (HK$0.01) | (HK$0.20) |
| Revenue Per Share | HK$1.41 | HK$0.64 | HK$1.03 | HK$1.25 | HK$1.20 |
| Shares | |||||
| Basic Shares Outstanding | 2.3B | 2.3B | 2.3B | 2.3B | 2.3B |
| Diluted Shares Outstanding | 2.3B | 2.3B | 2.3B | 2.3B | 2.3B |
| Profitability Metrics | |||||
| EBITDA | (34.2M) | 37.6M | (51.9M) | 376.8M | 19.1M |
| D&A | 85.3M | 25.4M | 67.9M | 171.1M | 230.8M |
| EBIT | (119.5M) | 12.2M | (119.9M) | 205.7M | (211.6M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026